Hyperoxia-induced NAD(P)H oxidase activation and regulation by map kinases in human lung endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 1 28-1, 2003, Pages

  Parinandi, Narasimham L ^a   Kleinberg, Michael A ^b   Usatyuk, Peter V ^a   Cummings, Rhett J ^a   Pennathur, Arjun ^a   Cardounel, Arturo J ^b   Zweier, Jay L ^a   Garcia, Joe G N ^a   Natarajan, Viswanathan ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Lung vascular endothelial cells; Mitogen activated protein kinases; Reactive oxygen species

Indexed keywords

DIPHENYLIODONIUM SALT; GLYCOPROTEIN GP 91; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OXIPURINOL; PROTEIN P22; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LUNG ENDOTHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 0037214029     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00123.2002     Document Type: Review

References (60)

1. -. Circ Res 83: 730-737, 1998.
2. Arabi S. Mitogen-activated protein kinases. Crit Care Med 30: S74-S79, 2002.
3. Babior BM. The NADPH oxidase of endothelial cells. IUBMB Life 50: 267-269, 2000.
4. Barazzone C, Horowitz S, Donati YR, Rodriguez I, and Piguet P-F. Oxygen toxicity in mouse lung: Pathways to cell death. Am J Respir Cell Mol Biol 19: 573-581, 1998.
5. Barbacanne M-A, Souchard J-P, Darblade B, Iliou J-P, Nepveu F, Pipy B, Bayard F, and Arnal JF. Detection of superoxide anion released extracellularly by endothelial cells using cytochrome C reduction, ESR, fluorescence and luminescence-enhanced chemiluminescence techniques. Free Radic Biol Med 29: 388-396, 2000.
6. Bayraktutan U, Blayney L, and Shah A. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 20: 1903-1911, 2000.
7. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Murphy TM, Chitano P, and Hoidal JR. NADPH oxidase promotes NF-κB activation and proliferation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282: L782-L795, 2002.
8. Bryan CL, Lewis RE, Owns SL, Emanuel B, and Jenkinson SG. Allopurinol inhibition of neutrophilic alveolar response during hyperoxia. J Appl Physiol 75: 357-363, 1993.
9. Buckley S, Driscoll B, Barsky L, Weinberg K, Anderson K, and Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am J Physiol Lung Cell Mol Physiol 277: L159-L166, 1999.
10. Bureau C, Bernad J, Chauouche N, Orfila C, Beraud M, Gonindard C, Alric L, Vinel JP, and Pipy B. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 276: 23077-23083, 2001.
11. Capellier G, Maupoil V, Boussat S, Laurent E, and Neidhardt A. Oxygen toxicity and tolerance. Minerva Anestesiol 65: 388-392, 1999.
12. Cherny VV, Henderson LM, Xu W, Thomas LL, and DeCoursey TE. Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. J Physiol 535: 783-794.
13. Clark LA and Moon RE. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am 5: 203-219, 1999.
14. Crapo JD, Barry DE, Fosme HA, and Shelburne J. Structural and biochemical changes in rat lungs occurring during exposure to lethal and adaptive doses of oxygen. Am Rev Respir Dis 122: 123-144, 1980.
15. Crapo JD, Hayatdavoudi G, Knapp MJ, Fracica PJ, Wolfe WG, and Piantadosi CA. Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 days. Am J Physiol Lung Cell Mol Physiol 267: L797-L806, 1994.
16. Dodd-O JM and Pearse DB. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 279: H303-H312, 2000.
17. Dupuy C, Ohayon R, Valent A, Noel-Hudson M, Deme D, and Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. J Biol Chem 274: 37265-37269, 1999.
18. 2-generating NADPH oxidase of phagocytes: Structure and methods of detection. Methods 9: 563-577, 1996.
19. Elsayed NM and Tierney DF. Hyperoxia and xanthine dehydrogenase/oxidase activities in rat lung and heart. Arch Biochem Biophys 273: 281-286, 1989.
20. Fisher AB, Al-Mehdi AB, and Muzykantov V. Activation of endothelial NADPH oxidase as the source of a reactive oxygen species in lung ischemia. Chest 116: 25S-26S, 1999.
21. Freeman BA, Turrens JF, Mirza Z, Crapo JD, and Young SL. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 44: 2591-2595, 1985.
22. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
23. Hohler B, Holzapfel B, and Kummer W. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 114: 29-37, 2000.
24. Jackson RM. Pulmonary oxygen toxicity. Chest 88: 900-905, 1985.
25. Jones DP. The role of oxygen concentration in oxidative stress: Hypoxic and hyperoxic models. In: Oxidative Stress, edited by Sies H. Orlando, FL: Academic, 1985, p. 152-195.
26. Jones SA, O'Donnell VB, Wood JD, Broughton JP, and Hughes EJ, and Jones OT. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol Heart Circ Physiol 271: H1626-H1634, 1996.
27. Jones RD, Hancock JT, and Morice AH. NADPH oxidase: A universal oxygen sensor? Free Radic Biol Med 29: 416-424, 2000.
28. Kazzaz JA, Xu J, Palaia TA, Mantell L, Fein AM, and Horowitz S. Cellular oxygen toxicity: Oxidant injury without apoptosis. J Biol Chem 271: 15182-15186, 1996.
29. Kinnula VL, Everitt JI, Whorton AR, and Crapo JD. Hydrogen peroxide production by alveolar type II cells, alveolar macrophages, and endothelial cells. Am J Physiol Lung Cell Mol Physiol 261: L84-L91, 1991.
30. Kinnula VL, Chang LY, Ho YS, and Crapo JD. Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo. Exp Lung Res 18: 655-673, 1992.
31. Kinnula VL, Mirza Z, Crapo JD, and Whorton AR. Modulation of hydrogen peroxide release from vascular endothelial cells by oxygen. Am J Respir Cell Mol Biol 9: 603-609, 1993.
32. Lal AS, Clifton AD, Rouse J, Segal AW, and Cohen P. Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38. Biochem Biophys Res Commun 259: 465-470, 1999.
33. Lehoux S and Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 32: 338-345, 1998.
34. Leusen JHW, Verhoeven AJ, and Roos D. Interactions between the components of the human NADPH oxidase: A review about the intrigues in the PHOX family. Front Biosci 1: D72-D90, 1996.
35. Mantell LL and Lee PJ. Signal transduction pathways in hyperoxia-induced lung cell death. Mol Genet Metab 71: 359-370, 2000.
36. Meyer JW and Schmitt ME. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett 472: 1-4, 2000.
37. Mohazzab KM, Kaminski PM, and Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol Heart Circ Physiol 266: H2568-H2572, 1994.
38. Moores HK, Beehler CJ, Hanley ME, Shanley PF, Stevens EE, Repine J, and Terada LS. Xanthine oxidase promotes neutrophil sequestration but not injection in hyperoxic lungs. J Appl Physiol 76: 941-945, 1994.
39. Natarajan V, Taher MM, Roehm B, Parinandi NL, Schmid HH, Kiss Z, and Garcia JG. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem 268: 930-937, 1993.
40. 2-induced activation of endothelial cell phospholipase D. Am J Physiol Lung Cell Mol Physiol 271: L400-L408, 1996.
41. Natarajan V, Scribner WM, Morris AJ, Roy S, Vepa S, Yang J, Wadgaonkar R, Reddy SPM, Garcia JGN, and Parinandi NL. Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. Am J Physiol Lung Cell Mol Physiol 281: L435-L449, 2001.
42. Obata T, Brown GE, and Yaffe MB. MAP kinase pathways activated by stress: The p38 MAPK pathway. Crit Care Med 28: N67-N77, 2000.
43. Panus PC, Wright SA, Chumley PH, Radi R, and Freeman BA. The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen-mediated cell injury. Arch Biochem Biophys 294: 695-702, 1992.
44. 2 concentration in rat brain after hyperoxic convulsions. J Appl Physiol 69: 17611766, 1990.
45. Pullar JM and Hampton MB. Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J Biol Chem 277: 19402-19407, 2002.
46. Sanders SP, Zweier JL, Kuppusamy P, Harrison SJ, Bassett DJ, Gabrielson EW, and Sylvester JT. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J Clin Invest 91: 46-52, 1993.
47. Shatwell KP and Segal AW. NADPH oxidase. Int J Biochem Cell Biol 28: 1191-1195, 1996.
48. Shiose A, Kuroda J, Kazuhiko T, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, and Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 272: 1417-1423, 2001.
49. Somers MJ, Burchfield JS, and Harrison DG. Evidence for a NADH/NADPH oxidase in human umbilical vein endothelial cells using electron spin resonance. Antioxid Redox Signal 2: 779-787, 2000.
50. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
51. Tian W, Zhang Z, and Cohen D. MAPK signaling and the kidney. Am J Physiol Renal Physiol 279: F593-F604, 2000.
52. Tsan MF. Superoxide dismutase and pulmonary oxygen toxicity. Proc Soc Exp Biol Med 214: 107-113, 1997.
53. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II. Involvement of p22phox and reactive oxygen species. Arterioscler Thrornb Vasc Biol 20: 940-948, 2000.
54. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov V, and Fisher AB. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 85: 682-689, 1999.
55. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thrornb Vasc Biol 20: 1430-1442, 2000.
56. Yamamori T, Inanami O, Nagahata H, Cui YD, and Kuwabara M. Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett 467: 253-258, 2000.
57. Yang S, Madyastha P, Bingel S, Ries W, and Key L. A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452-5458, 2001.
58. Yusa T, Crapo JD, and Freeman BA. Hyperoxia enhances lung and liver nuclear superoxide generation. Biochim Biophys Acta 798: 167-174, 1984.
59. Zweier JL, Duke SS, Kuppusamy P, Sylvester JT, and Gabrielson EW. Electron paramagnetic resonance evidence that cellular oxygen toxicity is caused by the generation of superoxide and hydroxyl free radicals. FEBS Lett 252: 12-16, 1989.
60. Zweier JL, Broderick R, Kuppusamy P, Thompson-Gorman S, and Lutty GA. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem 269: 24156-24162, 1994.